{"product_id":"kn-vrio-analysis","title":"Knowles Corporation (KN): VRIO Analysis [Mar-2026 Updated]","description":"\u003cbr\u003e\u003cp\u003eIs Knowles Corporation (KN) truly built to last? This VRIO analysis cuts straight to the core of its competitive advantage, dissecting whether its resources are Valuable, Rare, Inimitable, and Organized for success. Discover the critical strengths and potential vulnerabilities that define its market position right here.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eKnowles Corporation (KN) - VRIO Analysis: Precision Devices Segment Technology Portfolio (Capacitors, RF Filters, High-Q Inductors)\n\u003c\/h2\u003e\n\n\u003cp\u003eYou’re looking at the core engine of Knowles Corporation’s current growth story, the Precision Devices (PD) segment. Honestly, the numbers coming out of this area in 2025 show why management is so focused on these high-barrier markets. The technology portfolio - your capacitors, RF filters, and specialized inductors - isn't just supporting the business; it’s driving it forward.\u003c\/p\u003e\n\n\u003ch3\u003eValue: Revenue Generation in Mission-Critical Markets\u003c\/h3\u003e\n\u003cp\u003eThe value here is clear: it’s translating directly into top-line growth. In the third quarter of fiscal 2025, the Precision Devices segment pulled in $88.2 million in revenue. That’s a year-over-year jump of 12%, which is defintely strong performance given the broader macro environment. This revenue is tied to components like high-performance capacitors used in harsh applications like munitions and RF microwave filters for next-generation defense systems. The segment saw growth across defense, industrial, and EV end markets.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eQ3 2025 PD Revenue: \u003cstrong\u003e$88.2 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eYoY Revenue Growth (Q3 2025): \u003cstrong\u003e12%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eKey End Markets: Defense, Industrial, EV.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eRarity: Specialized Component Design\u003c\/h3\u003e\n\u003cp\u003eWhen we talk about rarity, we are looking at what competitors can’t easily source or replicate. Knowles Corporation’s focus on high-Q ceramic core inductors is a good example. These aren't off-the-shelf parts; they are engineered specifically for extreme thermal and mechanical stability, which is a must-have in defense and high-reliability industrial gear. While the company has a broad portfolio, the specific IP around integrating these high-spec components into complex military or industrial platforms is what makes them scarce in the marketplace. It’s not just the material; it’s the decades of application knowledge built into the design process.\u003c\/p\u003e\n\n\u003ch3\u003eImitability: The Barrier of Integration and Performance\u003c\/h3\u003e\n\u003cp\u003eImitability is moderate, leaning toward difficult for quick replication. It’s hard to copy the product quickly, but it’s even harder to copy the performance within a customer’s specific, certified system. To replicate the success, a competitor would need to match the 25.7% adjusted EBITDA margin the segment achieved in Q3 2025, which signals deep operational mastery over these complex products. Furthermore, the company cites accelerating design wins in mission-critical markets, suggesting a high switching cost for customers once a Knowles component is designed in. This customer intimacy creates a time-based barrier that is tough to overcome.\u003c\/p\u003e\n\n\u003ch3\u003eOrganization: Effective Commercialization and Margin Expansion\u003c\/h3\u003e\n\u003cp\u003eThe organization is clearly structured to capitalize on this technology. The segment’s operational execution in 2025 shows management is getting the most out of these specialized assets. The 12% revenue growth in Q3 2025 is proof of effective commercialization. Also, the expansion of the adjusted EBITDA margin by 200 basis points year-over-year to 25.7% in Q3 2025 shows they are managing costs and leveraging volume well. This operational discipline is key; having the rare tech is one thing, but effectively scaling production and maintaining profitability is where the organization truly shines.\u003c\/p\u003e\n\n\u003ch3\u003eCompetitive Advantage Scoring\u003c\/h3\u003e\n\u003cp\u003eHere’s a quick look at how these elements stack up against the VRIO framework for this specific technology portfolio.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eVRIO Dimension\u003c\/td\u003e\n\u003ctd\u003eAssessment\u003c\/td\u003e\n\u003ctd\u003eImplication for Competitive Advantage\u003c\/td\u003e\n\u003ctd\u003eScore (1-4)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue (V)\u003c\/td\u003e\n\u003ctd\u003eDrives \u003cstrong\u003e$88.2 million\u003c\/strong\u003e in Q3 2025 revenue and \u003cstrong\u003e12%\u003c\/strong\u003e growth.\u003c\/td\u003e\n\u003ctd\u003eParity to Temporary Advantage\u003c\/td\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRarity (R)\u003c\/td\u003e\n\u003ctd\u003eHigh-Q inductors for extreme stability are specialized\/scarce.\u003c\/td\u003e\n\u003ctd\u003eTemporary Advantage\u003c\/td\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInimitability (I)\u003c\/td\u003e\n\u003ctd\u003eIntegration into defense\/industrial specs creates high switching costs.\u003c\/td\u003e\n\u003ctd\u003eCostly to Imitate\u003c\/td\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrganization (O)\u003c\/td\u003e\n\u003ctd\u003eEffective commercialization leading to \u003cstrong\u003e25.7%\u003c\/strong\u003e segment margin.\u003c\/td\u003e\n\u003ctd\u003eOrganized to Exploit\u003c\/td\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompetitive Advantage\u003c\/td\u003e\n\u003ctd\u003eSustained Competitive Advantage\u003c\/td\u003e\n\u003ctd\u003eDurable moat in high-barrier markets.\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eSustained\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe combination of rare, valuable tech that the organization is effectively monetizing points toward a sustained advantage, at least until a major technological shift occurs in these defense\/industrial niches. Still, you need to watch capital allocation; cash from operations was $29 million in Q3 2025, which needs to fund R\u0026amp;D and debt reduction.\u003c\/p\u003e\n\u003cp\u003eFinance: draft 13-week cash flow projection incorporating Q4 2025 guidance by Friday.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eKnowles Corporation (KN) - VRIO Analysis: MedTech \u0026amp; Specialty Audio Expertise (Microphones and Balanced Armature Speakers)\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProvides stable revenue of \u003cstrong\u003e$65 million\u003c\/strong\u003e in Q3 2025, reflecting a \u003cstrong\u003e2%\u003c\/strong\u003e year-over-year increase for the segment. The segment achieved gross margins of \u003cstrong\u003e53%\u003c\/strong\u003e in Q3 2025, which is flat versus the year ago period. This segment is insulated by secular demand in hearing health and critical MedTech applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHigh; leadership in acoustic components for critical MedTech applications is not common. The company's design wins in these end markets contribute to its unique position.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHigh; deep application knowledge and reliability track record are built over decades, evidenced by the company's founding in 1946. The focus on custom engineering and extreme reliability in demanding applications creates barriers to entry.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eModerate; the company is organized to serve these markets, though margins faced mix pressure in Q3 2025, with the adjusted EBITDA margin at \u003cstrong\u003e43.7%\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSustained; the trust and reliability built into life-improving devices create high switching costs for MedTech customers.\u003c\/p\u003e\n\u003cp\u003eThe VRIO assessment for the MedTech \u0026amp; Specialty Audio segment is summarized below:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eVRIO Attribute\u003c\/th\u003e\n\u003cth\u003eAssessment\u003c\/th\u003e\n\u003cth\u003eSupporting Data\/Metric\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eQ3 2025 Revenue: \u003cstrong\u003e$65 million\u003c\/strong\u003e; YoY Growth: \u003cstrong\u003e2%\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRarity\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eLeadership in acoustic components for critical MedTech applications.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInimitability\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eDecades of deep application knowledge and reliability track record.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrganization\u003c\/td\u003e\n\u003ctd\u003ePartial\u003c\/td\u003e\n\u003ctd\u003eQ3 2025 Adjusted EBITDA Margin: \u003cstrong\u003e43.7%\u003c\/strong\u003e; faced mix pressure.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompetitive Advantage\u003c\/td\u003e\n\u003ctd\u003eSustained\u003c\/td\u003e\n\u003ctd\u003eHigh switching costs due to integration into life-improving devices.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eSpecific operational highlights for the segment include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eQ3 2025 Gross Margins: \u003cstrong\u003e53%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eExpected full-year 2025 organic revenue growth for the segment: \u003cstrong\u003e2% to 4%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe segment's performance is supported by strength in specialty audio and the hearing health market.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eKnowles Corporation (KN) - VRIO Analysis: Custom-Engineered Solutions \u0026amp; Application Intimacy\n\u003c\/h2\u003e\n\n\u003ch\u003e\u003ch\u003eValue\u003c\/h\u003e\u003c\/h\u003e\n\u003cp\u003eAllows Knowles to design unique products that solve specific customer problems, leading to design wins and backlog strength.\u003c\/p\u003e\n\u003cp\u003eThe value proposition is supported by financial metrics reflecting business performance and investment in core capabilities:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eYear Ended Dec 31, 2023\u003c\/th\u003e\n\u003cth\u003eYear Ended Dec 31, 2024 (Continuing Ops)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue from Continuing Operations\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$456.8 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$553.5 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYear-over-Year Revenue Growth (Continuing Ops)\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e21%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFull Year Free Cash Flow Margin\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e15%\u003c\/strong\u003e of Revenues\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResearch and Development Expenses as a Percentage of Revenues\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e11.1%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe MedTech \u0026amp; Specialty Audio (MSA) segment grew revenue by \u003cstrong\u003e8%\u003c\/strong\u003e from 2023 levels in 2024.\u003c\/p\u003e\n\n\u003ch\u003e\u003ch\u003eRarity\u003c\/h\u003e\u003c\/h\u003e\n\u003cp\u003eModerate; many firms offer components, but deep, custom engineering intimacy is less common at this scale.\u003c\/p\u003e\n\u003cp\u003eThe company emphasizes leveraging unique technologies through customer application intimacy.\u003c\/p\u003e\n\n\u003ch\u003e\u003ch\u003eImitability\u003c\/h\u003e\u003c\/h\u003e\n\u003cp\u003eModerate; requires specific engineering talent and close customer relationships that take time to build.\u003c\/p\u003e\n\u003cp\u003eInvestment in R\u0026amp;D demonstrates commitment to maintaining technical differentiation:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eResearch and development expenses as a percentage of revenues for the year ended December 31, 2023, were \u003cstrong\u003e11.1%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eResearch and development expenses as a percentage of revenues for the year ended December 31, 2022, were \u003cstrong\u003e10.7%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch\u003e\u003ch\u003eOrganization\u003c\/h\u003e\u003c\/h\u003e\n\u003cp\u003eHigh; CEO Jeffrey Niew emphasizes leveraging unique technologies through this intimacy for execution.\u003c\/p\u003e\n\u003cp\u003eOrganizational focus and execution are reflected in capital management and strategic direction:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFull Year 2023 Net Cash from Operating Activities was \u003cstrong\u003e$105 million\u003c\/strong\u003e, or \u003cstrong\u003e15%\u003c\/strong\u003e of revenues.\u003c\/li\u003e\n\u003cli\u003eFull Year 2024 Net Cash from Operating Activities was \u003cstrong\u003e$130 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe company returned \u003cstrong\u003e$48 million\u003c\/strong\u003e to shareholders through share buybacks in 2023.\u003c\/li\u003e\n\u003cli\u003eThe Board of Directors authorized an additional \u003cstrong\u003e$150 million\u003c\/strong\u003e for the Share Repurchase Program in early 2025, following repurchases of \u003cstrong\u003e$53.7 million\u003c\/strong\u003e in 2024.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch\u003e\u003ch\u003eCompetitive Advantage\u003c\/h\u003e\u003c\/h\u003e\n\u003cp\u003eTemporary; while strong now, competitors can hire away talent or partner to replicate this approach.\u003c\/p\u003e\n\u003cp\u003eForward-looking statements indicate continued reliance on this approach:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAs of Q3 2025, design activity and backlog remain strong, pointing to continued growth.\u003c\/li\u003e\n\u003cli\u003eThe company expects to achieve full year organic revenue growth of \u003cstrong\u003e6%\u003c\/strong\u003e in 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eKnowles Corporation (KN) - VRIO Analysis: High Gross Margin Structure (Expected above 50% for FY2025)\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Translates strong revenue growth into superior profitability, with Q3 gross margins at \u003cstrong\u003e53%\u003c\/strong\u003e. Full year 2025 gross margins are expected to be \u003cstrong\u003eabove 50%\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Moderate; achieving consistent margins above \u003cstrong\u003e50%\u003c\/strong\u003e is challenging compared to trailing twelve months (TTM) average gross profit margin of \u003cstrong\u003e43.51%\u003c\/strong\u003e and the 3-year average of \u003cstrong\u003e40.33%\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderate; requires cost control, premium pricing power, and favorable product mix.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e High; operational excellence is cited as a key driver for maintaining margins above \u003cstrong\u003e50%\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary; sustained margin levels depend heavily on avoiding commoditization in product ramps.\u003c\/p\u003e\n\u003cp\u003eKey financial metrics supporting the margin structure:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003cth\u003ePeriod\/Context\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 Gross Margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e53%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ3 2025 (Reported)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2025 Expected Gross Margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eAbove 50%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFull Year 2025 Outlook\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTTM Gross Profit Margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e43.51%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTrailing Twelve Months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3-Year Average Gross Profit Margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e40.33%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHistorical Average\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 2025 Revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$152.9 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ3 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 2025 Gross Profit\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$69.9 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ3 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eSupporting statistical and financial data points:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMedtech \u0026amp; Specialty Audio Segment Gross Margin was \u003cstrong\u003e53.1%\u003c\/strong\u003e in Q3 2024.\u003c\/li\u003e\n\u003cli\u003eQ1 2025 GAAP Gross Margin was \u003cstrong\u003e40.3%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eQ1 2025 Non-GAAP Gross Margin was \u003cstrong\u003e41.6%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eManagement projects MedTech \u0026amp; Specialty Audio adjusted EBITDA margins to reach the low \u003cstrong\u003e40%\u003c\/strong\u003e range for full year 2025.\u003c\/li\u003e\n\u003cli\u003ePrecision Devices segment adjusted EBITDA margins increased \u003cstrong\u003e140 basis points\u003c\/strong\u003e to \u003cstrong\u003e18.2%\u003c\/strong\u003e in Q1 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eKnowles Corporation (KN) - VRIO Analysis: Strategic Focus on High-Barrier End Markets\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue: Positions the company in sectors like Defense, MedTech, and Industrial Electrification, which have structural tailwinds.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe strategic focus is evidenced by the composition of continuing operations post-Consumer MEMS Microphone (CMM) divestiture.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eRevenue from Continuing Operations increased \u003cstrong\u003e21%\u003c\/strong\u003e over 2023 levels in 2024.\u003c\/li\u003e\n\u003cli\u003eMedTech \u0026amp; Specialty Audio (MSA) segment revenue grew \u003cstrong\u003e8%\u003c\/strong\u003e from 2023 to 2024.\u003c\/li\u003e\n\u003cli\u003ePrecision Devices (PD) segment saw strong growth, with Q3 2025 revenue of \u003cstrong\u003e$88.2 million\u003c\/strong\u003e, up \u003cstrong\u003e11.9%\u003c\/strong\u003e year-over-year.\u003c\/li\u003e\n\u003cli\u003eMSA segment revenue in Q3 2025 was \u003cstrong\u003e$64.7 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eQ2 2025 revenue of \u003cstrong\u003e$146 million\u003c\/strong\u003e was driven by the MSA segment's \u003cstrong\u003e10%\u003c\/strong\u003e year-over-year growth to \u003cstrong\u003e$67 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRarity: Moderate; many suppliers serve consumer electronics; focus on these specific industrial\/medical niches is less common.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe shift away from the high-volume, lower-differentiation CMM business supports this assessment.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe sale of the Consumer MEMS Microphones (CMM) business to Syntiant Corp. was for \u003cstrong\u003e$150 million\u003c\/strong\u003e in total consideration.\u003c\/li\u003e\n\u003cli\u003eThe CMM business sale was completed on December 30, 2024.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eImitability: High; gaining entry and qualification in defense\/medical supply chains takes years.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe acquisition of Cornell Dubilier (CD) brought immediate access to these high-barrier markets.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCornell Dubilier, acquired in Q4 2023, had annualized revenue of more than \u003cstrong\u003e$135 million\u003c\/strong\u003e at the time of announcement.\u003c\/li\u003e\n\u003cli\u003eCD's capacitor offerings serve demanding medtech, military, aerospace, and industrial electrification applications.\u003c\/li\u003e\n\u003cli\u003eA large energy sector order, valued at over \u003cstrong\u003e$75 million+\u003c\/strong\u003e, is expected to commence delivery in 2026.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization: High; the strategic pivot away from CMM shows clear organizational alignment with this focus.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOrganizational structure and capital allocation reflect the focus on Precision Devices and MedTech \u0026amp; Specialty Audio segments.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eMedTech \u0026amp; Specialty Audio (MSA)\u003c\/td\u003e\n\u003ctd\u003ePrecision Devices (PD)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 2025 Revenue (Millions USD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$64.7\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$88.2\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 YoY Revenue Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1.6%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e11.9%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ2 2025 Revenue (Millions USD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$67\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$79\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ2 2025 YoY Revenue Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e10%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e6%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 2025 Non-GAAP Diluted EPS Contribution (Implied)\u003c\/td\u003e\n\u003ctd\u003e(Part of total $0.33)\u003c\/td\u003e\n\u003ctd\u003e(Part of total $0.33)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage: Sustained; the qualification cycle in these markets acts as a long-term barrier to entry.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFinancial performance in the continuing operations demonstrates margin expansion potential from this focus.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eQ2 2025 operating margin reached \u003cstrong\u003e50.6%\u003c\/strong\u003e, sustained in the low-\u003cstrong\u003e50%\u003c\/strong\u003e range for the remainder of 2025.\u003c\/li\u003e\n\u003cli\u003eQ3 2025 Operating earnings were \u003cstrong\u003e$25.8 million\u003c\/strong\u003e, up from \u003cstrong\u003e$18.7 million\u003c\/strong\u003e in Q3 2024.\u003c\/li\u003e\n\u003cli\u003eFull Year 2023 Free Cash Flow margin was \u003cstrong\u003e15%\u003c\/strong\u003e of revenues.\u003c\/li\u003e\n\u003cli\u003eShare repurchases totaled \u003cstrong\u003e$55.0 million\u003c\/strong\u003e year to date as of Q3 2025, with \u003cstrong\u003e$139.0 million\u003c\/strong\u003e remaining authorization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eKnowles Corporation (KN) - VRIO Analysis: Proprietary Manufacturing Techniques and Scalability\n\u003c\/h2\u003e\n\u003cp\u003eProprietary Manufacturing Techniques and Scalability are central to Knowles Corporation's operational strategy, leveraging unique technology and global operational expertise.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Enables the company to deliver custom solutions at scale, supporting a 7.3% year-over-year revenue increase in Q3 2025, with Q3 2025 Revenues from Continuing Operations reported at $152.9 million.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Moderate; global scale is common, but proprietary techniques for miniaturization and high-performance components are not widely available.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderate; requires significant capital investment and process know-how that is difficult to replicate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e High; the company is actively increasing investments for capacity expansion, showing commitment to scaling, evidenced by Net Cash from Operations of $29.1 million in Q3 2025 and $20 million in share repurchases and $15 million in debt reduction during the quarter. The company is ramping up manufacturing capacity for the new Specialty Film product line through 2025 and into 2026.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained; the combination of proprietary process knowledge and scale creates a cost and quality advantage, demonstrated by the strong performance of the Precision Devices segment, which generated $88.2 million in revenue in Q3 2025, an 11.9% year-over-year increase.\u003c\/p\u003e\n\n\u003cp\u003eKey financial metrics supporting scalability and operational strength in Q3 2025 include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eRevenues from Continuing Operations: $152.9 million\u003c\/li\u003e\n\u003cli\u003eNon-GAAP Diluted EPS: $0.33, up 22.2% year-over-year\u003c\/li\u003e\n\u003cli\u003eOperating Margin: 16.9%\u003c\/li\u003e\n\u003cli\u003eNet Cash Provided by Operating Activities: $29.1 million\u003c\/li\u003e\n\u003cli\u003eFull Year 2025 Organic Growth Expectation: 6%\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eSegment revenue breakdown for Q3 2025 illustrates the scale and focus:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eSegment\u003c\/td\u003e\n\u003ctd\u003eQ3 2025 Revenue (Millions USD)\u003c\/td\u003e\n\u003ctd\u003eYear-over-Year Growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrecision Devices (PD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$88.2\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e11.9%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedTech \u0026amp; Specialty Audio (MSA)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$64.7\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1.6%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cbr\u003e\u003ch2\u003eKnowles Corporation (KN) - VRIO Analysis: Strong Balance Sheet and Financial Flexibility\n\u003c\/h2\u003e\n\u003cp\u003e\n\u003ch\u003e\u003ch\u003eValue\u003c\/h\u003e\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003e\nAllows for capital returns, with net cash provided by operating activities of \u003cstrong\u003e$29.1 million\u003c\/strong\u003e in Q3 2025, funding share repurchases and debt reduction.\n\u003c\/p\u003e\n\u003cp\u003e\n\u003ch\u003e\u003ch\u003eRarity\u003c\/h\u003e\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003e\nModerate; a net debt leverage ratio of only \u003cstrong\u003e0.6x\u003c\/strong\u003e as of September 30, 2025, is lean compared to many peers.\n\u003c\/p\u003e\n\u003cp\u003e\n\u003ch\u003e\u003ch\u003eImitability\u003c\/h\u003e\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003e\nHigh; this level of financial health is the result of disciplined capital allocation over time.\n\u003c\/p\u003e\n\u003cp\u003e\n\u003ch\u003e\u003ch\u003eOrganization\u003c\/h\u003e\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003e\nHigh; management actively uses this flexibility.\n\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\nRepurchased \u003cstrong\u003e$20 million\u003c\/strong\u003e in shares in Q3 2025.\n\u003c\/li\u003e\n\u003cli\u003e\nReduced debt by \u003cstrong\u003e$15 million\u003c\/strong\u003e during Q3 2025.\n\u003c\/li\u003e\n\u003cli\u003e\nYear to date, repurchased \u003cstrong\u003e3.12 million\u003c\/strong\u003e shares for \u003cstrong\u003e$55.0 million\u003c\/strong\u003e.\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\n\u003ch\u003e\u003ch\u003eCompetitive Advantage\u003c\/h\u003e\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003e\nSustained; financial strength provides a buffer against downturns and funding for strategic moves.\n\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eAmount\u003c\/td\u003e\n\u003ctd\u003eDate\/Period\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash and Cash Equivalents\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$92.5 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSeptember 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Debt\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$176.3 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSeptember 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Debt\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$83.8 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSeptember 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrailing 12-Month Adjusted EBITDA\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$133.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTrailing 12 Months ended September 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Debt Leverage Ratio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e0.6x\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSeptember 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash from Operating Activities\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$66.8 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNine Months ended September 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eShares Outstanding\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e85,151,884\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOctober 24, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cbr\u003e\u003ch2\u003eKnowles Corporation (KN) - VRIO Analysis: Intellectual Property and Trade Secret Protection\n\u003c\/h2\u003e\n\u003cp\u003eIntellectual Property and Trade Secret Protection as a source of competitive advantage.\u003c\/p\u003e\n\n\u003ch3\u003eValue: Protects core technology, especially in balanced armature devices, preventing direct imitation by competitors.\u003c\/h3\u003e\n\u003cp\u003eThe value is evidenced by the carrying value of the underlying assets on the balance sheet and the successful defense of core technology.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eDate\u003c\/th\u003e\n\u003cth\u003eGoodwill (Millions USD)\u003c\/th\u003e\n\u003cth\u003eOther Intangible Assets, Net (Millions USD)\u003c\/th\u003e\n\u003cth\u003eTotal Intangible Assets (Millions USD)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDecember 31, 2023\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e270.2\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e145.3\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e415.5\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJune 30, 2023\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e471.0\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e79.3\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e550.3\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJune 30, 2024\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e291.2\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e177.3\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e468.5\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe company reported Free Cash Flow of \u003cstrong\u003e$105 million\u003c\/strong\u003e, or \u003cstrong\u003e15%\u003c\/strong\u003e of 2023 revenues of \u003cstrong\u003e$456.8 million\u003c\/strong\u003e, demonstrating financial capacity to invest in and defend these assets.\u003c\/p\u003e\n\n\u003ch3\u003eRarity: Moderate; many tech firms have IP, but Knowles has a documented history of successfully defending core technology in trade secret cases.\u003c\/h3\u003e\n\u003cp\u003eThe rarity is supported by specific, successful legal outcomes against direct competitors in core technology areas.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eWon an International Trade Commission (ITC) Initial Determination in Investigation No. \u003cstrong\u003e337-TA-1186\u003c\/strong\u003e finding trade secret misappropriation.\u003c\/li\u003e\n\u003cli\u003eThe resulting order bars imports for a duration of \u003cstrong\u003e26-year\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe judge's decision was detailed in a \u003cstrong\u003e129-page\u003c\/strong\u003e document.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eImitability: High; legal precedents and established IP portfolios are extremely difficult for new entrants to overcome.\u003c\/h3\u003e\n\u003cp\u003eThe difficulty of imitation is demonstrated by the scope of the legal protection secured against a competitor relying on stolen secrets for balanced armature (BA) devices.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe recommended remedy included barring imports of offending BA devices and any downstream products containing them.\u003c\/li\u003e\n\u003cli\u003eThe general trend shows that trade secret litigation in federal court is on the rise, with over \u003cstrong\u003e1,200 cases\u003c\/strong\u003e filed last year, while patent cases fell to their lowest levels since \u003cstrong\u003e2010\u003c\/strong\u003e in 2023.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eOrganization: High; the company has demonstrated a willingness to vigorously protect its IP assets.\u003c\/h3\u003e\n\u003cp\u003eThe company's organizational commitment is shown through its actions and scale.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe CEO stated the company will \u003cstrong\u003e'vigorously protect our intellectual property.'\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe company operates globally with approximately \u003cstrong\u003e5,500\u003c\/strong\u003e employees in \u003cstrong\u003e11 countries\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe company has a history of share repurchases, returning \u003cstrong\u003e$48 million\u003c\/strong\u003e to shareholders in 2023.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCompetitive Advantage: Sustained; legal barriers and established IP rights provide a long-term shield.\u003c\/h3\u003e\n\u003cp\u003eThe sustained advantage is supported by the long-term nature of the legal remedy and the high success rate in this type of litigation.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe ITC order secured a \u003cstrong\u003e26-year\u003c\/strong\u003e import ban.\u003c\/li\u003e\n\u003cli\u003ePlaintiffs in trade secret cases who proceed to trial have an \u003cstrong\u003e86 percent\u003c\/strong\u003e win rate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eKnowles Corporation (KN) - VRIO Analysis: Specialty Film Product Line Growth Potential\n\u003c\/h2\u003e\n\u003cp\u003eThe integration of the Cornell Dubilier (CD) business, which includes the specialty film capacitor line, is a key strategic move following its acquisition for a total cost of $263 million, consisting of a $140 million cash payment and an interest-free seller note of $123 million at announcement. CD previously generated annualized revenue of more than $135 million.\u003c\/p\u003e\n\u003cp\u003e\n\u003ch\u003eValue\u003c\/h\u003e\n\u003c\/p\u003e\u003cp\u003eRepresents a new, expected revenue growth area for 2026, stemming from the Cornell Dubilier acquisition. Management has raised expectations for total company organic growth rates to the high end of the 4% to 6% range for 2026. Initial revenue contributions from the specialty film line are expected in the latter half of 2025, with more substantial growth in 2026.\u003c\/p\u003e\n\u003ch\u003eRarity\u003c\/h\u003e\n\u003cp\u003eTemporary; it is a newly integrated line, but the technology itself is known in the capacitor space. The ramp-up of manufacturing capacity for the new Specialty Film product line is ongoing through 2025 and into 2026.\u003c\/p\u003e\n\u003ch\u003eImitability\u003c\/h\u003e\n\u003cp\u003eModerate; competitors can acquire similar assets, but ramping up production efficiently takes time. The Precision Devices segment, which houses the acquired business, saw revenue of $88 million in Q3 2025, up 12% year-over-year.\u003c\/p\u003e\n\u003ch\u003eOrganization\u003c\/h\u003e\n\u003cp\u003eModerate; the company is increasing capital spending to ramp up capacity, showing focus. Full-year capital spending for 2025 is targeted at approximately 5% of revenues. The Precision Devices segment reported gross margins of 41.5% in Q3 2025.\u003c\/p\u003e\n\u003ch\u003eCompetitive Advantage\u003c\/h\u003e\n\u003cp\u003eTemporary; this is a nascent growth driver that needs to prove its long-term margin contribution. Knowles received a $75 million+, multi-year order for high-performance capacitors in the Energy market, with revenue expected mid-2026.\u003c\/p\u003e\n\u003cp\u003eThe integration progress and segment performance are detailed below:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eQ3 2024 (Continuing Ops)\u003c\/td\u003e\n\u003ctd\u003eQ3 2025\u003c\/td\u003e\n\u003ctd\u003eContext\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrecision Devices Revenue (Millions USD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$79\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$88\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eYear-over-year growth of \u003cstrong\u003e12%\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Company Revenue (Millions USD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$143\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$153\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eYear-over-year growth of \u003cstrong\u003e7%\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 Cash from Operations (Millions USD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$53\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$29\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ3 2025 was at the high end of guidance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eKey financial and operational milestones related to the integration include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe acquisition of Cornell Dubilier was completed in the fourth quarter of 2023.\u003c\/li\u003e\n\u003cli\u003eThe company's non-GAAP diluted EPS from continuing operations for Q3 2024 was $0.26.\u003c\/li\u003e\n\u003cli\u003eThe company's Q3 2025 non-GAAP diluted EPS from continuing operations was $0.33.\u003c\/li\u003e\n\u003cli\u003eThe company has an aggregate of approximately $194 million available under its stock repurchase program as of February 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFinance: draft 13-week cash view by Friday.\u003c\/p\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45516194775189,"sku":"kn-vrio-analysis","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/kn-vrio-analysis.png?v=1740188887","url":"https:\/\/dcf-model.com\/fr\/products\/kn-vrio-analysis","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}